Research team’s ongoing work on using stem cells to encourage brain and muscle to self-repair has celebrated successes
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.
Using state-of-the art sequencing technology, Medicine by Design-funded scientists have revealed how stem cells are able to generate new blood cells throughout our life, and how these same cellular mechanisms can evade chemotherapy to survive and cause relapse many years later.
Medicine by Design-funded researchers develop a new tool for scooping contents of individual cells from their local environment
Scientists can now select individual cells from their local environment & study their molecular contents. The new tool will enable a deeper study of stem cells and other rare cell types for diagnostics & therapy.
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.
Medicine by Design seeds two strategic projects: An international partnership with the University of Cambridge and a new forum that will foster collaboration between clinicians, scientists and industry
$300,000 investment will accelerate new therapies and create new research tools.
U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
A new platform brings together genome editing with magnetic cell sorting to reveal new drug targets for cancer and regenerative medicine
Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only
Toronto investigators part of international team receiving $4-million (U.S.) award from Chan Zuckerberg Initiative
The project, part of the Human Cell Atlas, seeks to build a more complete map of the human liver and is a “direct extension” of the work the Toronto team has already done with support from Medicine by Design
Professor Shulamit Levenberg will serve as Medicine by Design’s first Scholar in Residence from July 15 to August 15, 2019.
Medicine by Design researchers featured in Science story on reprogramming cells into neurons to treat brain injury
Cindi Morshead and Maryam Faiz talk about the work they presented at the annual meeting of the Society for Neuroscience.
Finding inspiration from an unlikely source, a team led by Andras Nagy at Sinai Health System has an answer for one of the most pressing questions in cell therapy: how to ensure its safety
How the first “map” of the human liver came together through a collaboration sown by Medicine by Design
Believed to be the first time a human organ has been charted at the single-cell level, the research illuminates the basic biology of the liver in ways that could eventually increase the success of transplant surgery and enable viable regenerative medicine treatments for liver disease.